# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
IM Cannabis reported a 13% sequential increase in revenue for the three months ended March 31, 2024, hitting CA$10.7 million ($...
IM Cannabis (NASDAQ:IMCC) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.20)...
https://twitter.com/KevinSabet/status/1787569052782846142
https://www.marijuanamoment.net/florida-gop-formally-opposes-marijuana-legalization-ballot-initiative-clearing-path-for-desanti...
Cannabis stocks soared Tuesday following reports that the DEA will move to reschedule marijuana from a Schedule I to a Schedule...
https://www.wsj.com/finance/regulation/declassifying-cannabis-still-leaves-pot-stocks-in-limbo-26d417ec